Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27074007 | 0.90 | ACHE (0.44) | ACHEMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL27039791 | 0.87 | MAPT (0.50) | ACHEMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL27074024 | 0.79 | MAPT (0.53) | ACHEMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL10563531 | 0.77 | MAPT (0.48) | MAPTALDH1A1MEN1KMT2ATP53 | |
| SCHEMBL571684 | 0.77 | MAPT (0.54) | MAPTALDH1A1MEN1KMT2ATP53 | |
| SCHEMBL4680788 | 0.77 | ALDH1A1 (0.57) | ACHEMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL28730377 | 0.76 | MAPT (0.63) | ACHEMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL29550916 | 0.76 | MAPT (0.63) | ACHEMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL27039653 | 0.76 | ALOX15 (0.47) | MAPTALDH1A1MEN1KMT2ATP53 | |
| SCHEMBL27074023 | 0.73 | MAPT (0.57) | ACHEMAPTALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028364-A1 | CATIONIC CHROMENONES AND THEIR USE IN ONCOLOGY | FLORATEK PHARMA S A (CH) | 2026-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028364-A1 | CATIONIC CHROMENONES AND THEIR USE IN ONCOLOGY | NR3C2, MC2R, NR3C1 | ACHE 4638/4885MAPT 4264/4885ALDH1A1 3078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.